Last updated on May 2018

Deep Brain Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy


Brief description of study

The main objective of the study is twofold:

  1. Assess the clinical efficacy of DBS on epilepsy according to their number and severity at 1 year follow up.
  2. Perform a cost-effectiveness analysis from the perspective of Medicare at 1 and 2 years.

The study hypothesis is that thalamic DBS (neurostimulation of the anterior nucleus of the thalamus) will decrease significantly, the frequency (potentially 50% reduction in severe crises) of the most severe seizures, in at least 50% of patients who have drug-resistant partial epilepsy; and should also improve significantly the quality of life through a gain of independence in activities of daily life, the possible recovery of functional abilities, recovery of social or professional activities.

Clinical Study Identifier: NCT02076698

Contact Investigators or Research Sites near you

Start Over

Guillaume PENCHET, MD

University Hospital of Pellegrin
Bordeaux, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.